MTOR and cancer: Several works have revealed that one of the major growth regulatory pathways controlled by LKB1-AMPK is the mammalian target-of-rapamycin (mTOR) pathway that controls cell growth in all eukaryotes and is deregulated in most human cancers [148,149,150].